Gilead reveals remdesivir price, and it's in line with watchdog estimates
Four more biotech IPOs add to IPO boom
Heron Therapeutics gets FDA rejection for opioid alternative
Coalition of drugmakers to unveil $1B venture to pursue antibiotics
*please scroll down for all the latest news*